Congress

  • Show me the money

    Companies are under increased pressure to maximize the value of their assets, and with Big Data and data analytics, we’re in a highly competitive environment.”

  • Alphabet soup

    The Leahy–Smith America Invents Act (AIA) was seen as the most important new patent law in a half century when it was approved in 2011. The law basically moved the U.S. patent system from a “first to invent” to a “first inventor to file” system. It also allowed for inter...

  • Congress tries to pass trade secrets protection bill

    Some bipartisan members of Congress have once again backed a bill that attempts to stop the loss of hundreds of billions of dollars a year from the theft of corporate trade secrets.

  • Banks and cybersecurity from a regulatory and a risk perspective

    Banks are increasingly devoting more and more resources to face these threats. A cyber attack can cause significant monetary losses and reputational damage to a financial institution. But financial institutions also face another challenge—from their regulators—who are changing their approach to cybersecurity by emphasizing its importance and transforming it from...

  • After 'I do': Prognosticating the future of LGBT issues in the workplace

    There is no better way to close this six-part series on LGBT workplace issues than for me to don my Carnac the Magnificent garb and divine the future for employers. Imagine that I hold in my hand the following three hermetically sealed envelopes – the contents of which nobody knows....

  • Netflix announces generous new leave policy for new parents

    The day after Netflix’s announcement, Microsoft said its employees who are new parents would get an additional eight weeks of paid time off.

  • State sanctions remain possible even if Iran deal gets approved

    “I would advise state legislators interested in maintaining the traditional American position on Iran to pass any and all divestment measures they can, and use the full strength of the federal authorization to do so,” Northwestern Law Professor Eugene Kontorovich said.

  • Skeptical questions posed on Iran deal

    Kerry – and his administration colleagues – found themselves getting grilled about details in the agreement, and pressure is mounting on many Democrats to reject the deal.

  • The future of preemption

    For FDA (Food and Drug Administration)-regulated companies, federal preemption can provide a potentially powerful defense to state tort claims. In recent years, the U.S. Supreme Court has decided numerous preemption cases, each emphasizing the highly context-sensitive nature of the inquiry. Determining when preemption applies and how to deploy it to...

  • Federal Circuit tries to explain ‘unclear’ biologics law

    A recent ruling by judges from the U.S. Court of Appeals for the Federal Circuit makes it more likely that Sandoz soon may be able to start selling a biosimilar that treats cancer patients.

Next »

Advertisement. Closing in 15 seconds.